Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Neoadjuvant therapy and PCR through chemotherapy prior to surgery
Dr Michail Ignatiadis – Jules Bordet Institute, Brussels, Belgium
Neoadjuvant therapy and PCR through chemotherapy prior to surgery ( Dr Michail Ignatiadis – Jules Bordet Institute, Brussels, Belgium )
17 May 2012
Minimising recurrence by using most effective treatment
Prof Fabrice Andre – Institut Gustave Roussy, Paris, France
Minimising recurrence by using most effective treatment ( Prof Fabrice Andre – Institut Gustave Roussy, Paris, France )
17 May 2012
Overcoming drug resistance and targeting critical pathways
Dr Larry Norton – Memorial Sloan-Kettering Cancer Center, New York, USA
Overcoming drug resistance and targeting critical pathways ( Dr Larry Norton – Memorial Sloan-Kettering Cancer Center, New York, USA )
17 May 2012
Heterogeneity of tumours and the challenges of biomarker development
Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy
Heterogeneity of tumours and the challenges of biomarker development ( Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy )
17 May 2012
Targeting the PI3K/mTOR pathway
Dr Lewis Cantley – Dana-Farber Cancer Institute, Boston, USA
Targeting the PI3K/mTOR pathway ( Dr Lewis Cantley – Dana-Farber Cancer Institute, Boston, USA )
17 May 2012
Use of metformin against breast cancer
Prof Alastair Thompson – University of Dundee, UK
Use of metformin against breast cancer  ( Prof Alastair Thompson – University of Dundee, UK )
17 May 2012
Cancer genes differ in different parts of a tumour
Prof Charles Swanton - CRUK London Research Institute and UCL, UK
Cancer genes differ in different parts of a tumour ( Prof Charles Swanton - CRUK London Research Institute and UCL, UK )
17 May 2012
Targeting DNA damage response and repair excluding PARP for triple negative brea...
Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden
Targeting DNA damage response and repair excluding PARP for triple negative breast cancer ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )
17 May 2012
Endocrine therapy resistance and next generation sequencing
Prof Matthew Ellis - Washington University, USA
Endocrine therapy resistance and next generation sequencing ( Prof Matthew Ellis - Washington University, USA )
17 May 2012
Molecular characterisation of breast cancer: the mutational landscape
Prof Sam Aparicio - University of British Columbia, Vancouver, Canada
Molecular characterisation of breast cancer: the mutational landscape ( Prof Sam Aparicio - University of British Columbia, Vancouver, Canada )
17 May 2012
Metabolism in malignant tumors: a new approach for treating breast cancer
Prof Tak Mak - University of Toronto, Canada
Metabolism in malignant tumors: a new approach for treating breast cancer ( Prof Tak Mak - University of Toronto, Canada )
17 May 2012
Criteria required before implementation of whole genome arrays in clinical pract...
Prof Daniel Hays - University of Michigan, Ann Arbor, USA
Criteria required before implementation of whole genome arrays in clinical practice ( Prof Daniel Hays - University of Michigan, Ann Arbor, USA )
17 May 2012